drugset / Trial / NCT00201435

Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC

NCT00201435

Phase 2/3 Completed 224 enrolled Norwegian Breast Cancer Group
RandomizedParallel-groupOpen-labelTreatment

Summary

We want to compare Taxol given weekly with Taxotere given every 3 week both in comination with Xeloda. We are going to compare time to treatment failure and quality of life.

Timeline

Start
2005-03
Primary completion
2008-01
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule
Subject Paclitaxel Small molecule
Background Capecitabine Small molecule

Indications